Correlation Between Phio Pharmaceuticals and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Tscan Therapeutics, you can compare the effects of market volatilities on Phio Pharmaceuticals and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Tscan Therapeutics.
Diversification Opportunities for Phio Pharmaceuticals and Tscan Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Phio and Tscan is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and Tscan Therapeutics
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to generate 23.0 times more return on investment than Tscan Therapeutics. However, Phio Pharmaceuticals is 23.0 times more volatile than Tscan Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.39 per unit of risk. If you would invest 223.00 in Phio Pharmaceuticals Corp on October 23, 2024 and sell it today you would earn a total of 54.00 from holding Phio Pharmaceuticals Corp or generate 24.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phio Pharmaceuticals Corp vs. Tscan Therapeutics
Performance |
| Timeline |
| Phio Pharmaceuticals Corp |
| Tscan Therapeutics |
Phio Pharmaceuticals and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phio Pharmaceuticals and Tscan Therapeutics
The main advantage of trading using opposite Phio Pharmaceuticals and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |